Multiple Indian companies across various sectors have released their unaudited financial results for the third quarter of fiscal year 2026, ended December 31, 2025. The announcements were made in compliance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Key Financial Highlights

The companies reported varied performance metrics for the quarter, with detailed breakdowns of their operational and financial parameters.

Medico Remedies Limited Performance

Medico Remedies Limited announced its quarterly results with the following key metrics:

Honda India Power Products Limited Results

Honda India Power Products Limited reported substantial operational metrics for the quarter:

LKP Finance Limited Financial Summary

LKP Finance Limited disclosed its quarterly performance with these highlights:

Regulatory Compliance and Documentation

All companies have ensured compliance with regulatory requirements by filing their detailed financial results with stock exchanges. The complete formats of quarterly financial results are available on BSE and NSE websites, as well as on the respective company websites.

Additional Corporate Developments

Several companies also announced other corporate actions alongside their financial results:

• HEM Holdings and Trading Limited has scheduled an Extra-Ordinary General Meeting for March 12, 2026, to be conducted through video conferencing
• LKP Finance Limited has initiated a postal ballot process for member approvals through remote e-voting
• Avonmore Capital & Management Services Limited reported consolidated results including figures from associate companies

Market Access and Transparency

The companies have made their financial information readily accessible to stakeholders through multiple channels. Detailed financial statements, auditor reports, and supplementary information are available on company websites and stock exchange portals. This ensures transparency and enables informed decision-making by investors and market participants.

The quarterly results reflect the operational performance of these companies across diverse sectors including pharmaceuticals, power products, finance, and chemicals during the third quarter of fiscal year 2026.

HEM Holdings and Trading Limited announced its unaudited standalone financial results for the quarter ended December 31, 2025, pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Board of Directors approved these results during their meeting held on February 13, 2026, demonstrating exceptional operational performance and significant growth across key financial metrics.

Quarterly Financial Performance

The company delivered outstanding financial results for Q3 FY26, showcasing substantial growth compared to the corresponding quarter of the previous year.

The company's revenue from operations increased dramatically from ₹7.13 lakhs in Q3 FY25 to ₹20.71 lakhs in Q3 FY26. Notably, the company reported no other income during the current quarter, compared to ₹1.50 lakhs in the corresponding quarter of the previous year.

Nine-Month Performance Analysis

For the nine-month period ended December 31, 2025, HEM Holdings demonstrated exceptional growth momentum across all key parameters.

The nine-month results reflect the company's strong operational efficiency, with total expenses decreasing from ₹11.83 lakhs in the corresponding period of FY25 to ₹7.79 lakhs in FY26.

Cost Structure and Operational Efficiency

The company maintained a lean cost structure during Q3 FY26, with total expenses of only ₹0.63 lakhs compared to ₹2.64 lakhs in Q3 FY25. The expense breakdown included finance costs of ₹0.01 lakhs and other expenses of ₹0.62 lakhs, with no employee benefit expenses, depreciation, or material costs reported. This efficient cost management contributed significantly to the improved profitability margins.

Regulatory Compliance and Review

The financial results were prepared in accordance with Indian Accounting Standard 34 "Interim Financial Reporting" (Ind AS 34) and reviewed by B.M. Gattani & Co., Chartered Accountants. The statutory auditors conducted a limited review and confirmed that the results comply with recognition and measurement principles under the Companies Act, 2013.

The company maintained its paid-up equity share capital at ₹24.00 lakhs with a face value of ₹10.00 per share throughout the reporting periods. No investor complaints were pending at the end of the quarter, and the company operates with only one reportable segment.